Navigation Links
LABS, Inc. Launches Suite of Next-Generation Test Offerings; Focuses on Expanding Complex Biologic Testing Portfolio in 2012
Date:3/21/2012

CENTENNIAL, Colo., March 21, 2012 /PRNewswire/ -- LABS, Inc., a global, full-service testing laboratory with more than 30 years of expertise in regulated testing for human organs, cells, tissues and implantable biologic products and devices, this month launches a group of new laboratory tests suitable for screening complex biologic products. These new offerings will allow the company to provide innovative solutions with faster turnaround times to meet the needs of existing and future clients.

"The medical and scientific industries are creating products that do not readily conform to the legacy compendial assays. As such, LABS is committed to taking a leadership role to provide alternative solutions for these complex biologic products, which often require faster test results from smaller sample volumes," said Chad Ronholdt, Vice President Strategic Development of LABS, Inc.

LABS this month launches five new tests:

  • Novartis Procleix Tigris System: a new, fully automated Nucleic Acid Testing (NAT) platform for infectious disease screening. NAT is the gold standard to detect HIV-1, Hepatitis B and Hepatitis C viruses for the purposes of human organ, eye, cell and tissue donor eligibility screening.  LABS is the only complex biologic testing facility in North America to offer this new, superior platform. The automated platform minimizes operator-induced variability and allows LABS to capitalize on efficiencies that the older, manual donor eligibility methods cannot offer.
  • MYcoSEQ™ Mycoplasma Real-Time Polymerase Chain Reaction (RT-PCR) Detection Assay: a robust, reliable and efficient method for detecting more than 90 species of Mycoplasma contamination within seven days. This new assay, independently validated by LABS, is ideal for the evaluation of upstream and mid-stream processing samples during the manufacturing of human biologic and cellular-based products and/or reagents. The assay is not intended to be used for final lot release unless a secondary validation is performed and incorporated into a regulatory product application.
  • VDmax sterilization and dose audits: a simplified validation method for sterilizing human allograft products such as bone, osteobiologic putties and soft tissues comprised of ligaments and tendons, through the use of radiation. This method is also very useful for the validation of associated materials used during the processing of allograft products such as packaging, syringes, sample containers, etc. Upon successful completion of the validation, quarterly dose audits are performed to confirm that the sterilization dose initially determined for the product is still appropriate over time. 
  • Blood spot and buccal swab Human Leukocyte Antigen (HLA) analysis: a simplified method, requiring lower sample volume, for collecting DNA samples for HLA typing, which is used to match donors and recipients for cell-based transplants and transfusions. These new methods are particularly valuable in situations when whole blood samples are scarce or unavailable.  The blood spot method uses a single drop of blood applied to an FTA™ card, which contains a proprietary formula to capture and preserve the blood sample for testing. The buccal swab method doesn't rely on the availability of blood to collect the required DNA for analysis, instead using a sterile swab to collect cells containing DNA from the inside of a cheek.
  • Endotoxin testing: endotoxins are toxic substances derived from gram negative bacteria and can be associated with biologics, biopharmaceuticals, medical devices, packaging materials and water purification systems. Complex biologic products present a formidable challenge to the standard endotoxin instruments and testing methods since there is typically an inherent level of inhibitory substances present within them. LABS has extensive experience with mitigating these inhibitory factors, which will give clients accurate, reliable and rapid results for screening and/or lot release of biopharmaceuticals, complex biologic products or medical device products or packaging.  

"We are proud to be at the forefront of developing and implementing cutting-edge testing solutions to meet the rapidly evolving biologic landscape, particularly for industries like biopharmaceuticals, cellular therapies, regenerative medicine and tissue engineering products," said Elizabeth Hearty, Chief Executive Officer of LABS, Inc.

LABS is the leading donor eligibility testing laboratory in the nation. The Company obtained this industry leadership position in the donation community by providing highly customized solutions using the most innovative technologies, delivering precise results, and maintaining an unmatched attention to customer service and quality. As an FDA registered, ISO, CLIA and CAP certified testing laboratory, LABS clients' samples are handled and processed with the most reproducible and reliable methods available. Additionally, LABS is uniquely capable of delivering highly complex and customized solutions to clients creating a variety of rapidly evolving complex biologics.

About LABS, Inc.
LABS, Inc. is a global, full-service testing laboratory with more than 30 years of expertise in regulated testing for human organs, cells, tissues and implantable biologic products and devices. LABS provides an intimate customer service experience, which results in personalized laboratory solutions for clients in any stage of the product development lifecycle: donor eligibility, R&D, processing and validation and final lot release. 

LABS has an established and trusted record of personalized service, compliance and integrity. The Company serves a variety of industries that are focused on advancing and understanding biologic-based products.

The company is headquartered in Centennial, CO with satellite facilities in St. Louis, MO and Philadelphia, PA. LABS receives sample shipments from across the globe and performs testing for 10 nations outside of the U.S.: Australia (TGA certified), Canada, Germany, Italy, Japan, Singapore, South Korea, Sweden, Switzerland and the United Kingdom.  To learn more, visit www.labs-inc.org.


'/>"/>
SOURCE LABS, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology news :

1. The Rett Syndrome Research Trust launches operations
2. LIAI launches new division to look at novel approaches to heart disease and inflammation
3. Complete Genomics launches, becomes worlds first large-scale human genome sequencing company
4. TheVisualMD.com launches new animated 3-D views of human body in action
5. International Council for Science launches major research program on natural disasters
6. ICSU launches new program to understand the human impact on Earths life-support systems
7. North American environmental commission launches trinational vaquita conservation plan
8. OSAs ISP launches with research on breathing disorders and congenital heart defects
9. Futronic Launches FS22 Fingerprint Access Control Device
10. Springer launches Food Security
11. From sheet metal elements to host cells: DFG launches 10 new collaborative research centers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/7/2018)... ... September 06, 2018 , ... Sensors Midwest (#SensorsMW18), ... Sensors Expo & Conference , announces their partnership with Fraunhofer USA Center ... IoT Enabled Industrial IoT Certification Program. Taking place on October 17, 2018 at ...
(Date:9/1/2018)... ... 31, 2018 , ... Right this minute, Frenchman Ben Lecomte is hard at work on his ... he’s taken on a new challenge: going from Tokyo to San Francisco, churning his limbs ... on the support boat. As the first expedition of its kind, The Swim is far ...
(Date:8/31/2018)... ... August 30, 2018 , ... CallTower is pleased to ... than 20-years of telecommunications experience and over ten years in executive leadership. Prior to ... by CallTower in early 2018. , In this new role, Jason ...
Breaking Biology News(10 mins):
(Date:8/21/2018)... ... ... The Connecticut Technology Council (CTC) and Marcum LLP today announce the 2018 ... Connecticut. This year’s group of top-ranked companies will be honored at the new ConnectiTECH ... in Hartford. A complete list of the Marcum Tech Top 40 is included below. ...
(Date:8/17/2018)... ... August 16, 2018 , ... KCAS Bioanalytical ... announce the expansion of their team. Dr. Dawn Dufield, Ph.D., joins KCAS as ... large molecule LC-MS/MS group that will specialize in developing quantitative LC-MS/MS assays for ...
(Date:8/17/2018)... Columbia (PRWEB) , ... August 17, 2018 , ... ... International Society for Biological and Environmental Repositories (ISBER) is pleased to announce the ... , The Fourth Edition publication, originally released in January 2018, is a practice-changing ...
(Date:8/14/2018)... ... August 14, 2018 , ... Buprenorphine ... use disorder. BUP is often prescribed as a sublingual co-formulation with the opioid ... this webinar, participants will learn from a review of the pharmacokinetics of BUP, ...
Breaking Biology Technology: